Victrex/£VCT

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Victrex

Victrex PLC, founded in 1993 and headquartered in Thornton Cleveleys, UK, is a company that specializes in the manufacturing of high-performance polymeric solutions. It operates in the Specialty Chemicals sector within the materials industry, offering products made primarily from PEEK and PAEK-based materials used in a wide range of sectors including automotive, aerospace, energy, electronics, and medical. Its operations focus on both the development and production of these advanced polymer solutions, catering to both industrial and medical applications across various global markets.

Ticker

£VCT
Sector

Primary listing

LSE

Industry

Chemicals

Employees

1,131

Victrex Metrics

BasicAdvanced
£614M
20.70
£0.34
-
£0.60
8.44%

What the Analysts think about Victrex

Analyst ratings (Buy, Hold, Sell) for Victrex stock.

Bulls say / Bears say

Jefferies upgraded Victrex to 'Buy', citing a compelling recovery opportunity in FY25 driven by demand resurgence in most segments of Sustainable Solutions, excluding automotive, and potential favorable raw material cost developments. (Investing.com)
Deutsche Bank upgraded Victrex to 'Buy', highlighting the company's strong cash generation, completion of major capacity expansion, and attractive valuation metrics, including a 6.6% free cash flow yield and a 6.2% dividend yield for FY25. (Proactive Investors)
Victrex reported a 20% increase in sales volumes to 898 tonnes in Q1 FY25, with revenue growing by 9% to £66.6 million, indicating potential for continued growth despite challenges in the medical division. (Proactive Investors)
Victrex's CEO Jakob Sigurdsson stepped down after almost eight years, coinciding with a 3% decline in Q3 revenue to £71.5 million and weaker sales volumes, raising concerns about leadership stability and financial performance. (Proactive Investors)
JPMorgan downgraded Victrex's stock rating from 'Overweight' to 'Neutral' and reduced the price target to £10.50, citing concerns over weaker macroeconomic data from the U.S., ongoing trade tariff uncertainties, and a significant decline in return on invested capital. (Investing.com)
Victrex reported a 17% decline in pretax profit to £23.2 million in H1 FY25, with average selling prices dropping to £72.3/kg, leading to a gross margin contraction of 390 basis points to 44.1%, indicating profitability challenges. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Victrex Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Victrex Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £VCT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs